FI891357A - Process for Preparation of Salicylic Acid Derivative against Dandruff Skin Diseases - Google Patents

Process for Preparation of Salicylic Acid Derivative against Dandruff Skin Diseases Download PDF

Info

Publication number
FI891357A
FI891357A FI891357A FI891357A FI891357A FI 891357 A FI891357 A FI 891357A FI 891357 A FI891357 A FI 891357A FI 891357 A FI891357 A FI 891357A FI 891357 A FI891357 A FI 891357A
Authority
FI
Finland
Prior art keywords
salicylic acid
preparation
acid derivative
skin diseases
against dandruff
Prior art date
Application number
FI891357A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI891357A0 (en
FI94314B (en
FI94314C (en
Inventor
Konrad Minninger
David Tang
Rainer Oberhagemann
Original Assignee
Konrad Minninger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Konrad Minninger filed Critical Konrad Minninger
Publication of FI891357A0 publication Critical patent/FI891357A0/en
Publication of FI891357A publication Critical patent/FI891357A/en
Publication of FI94314B publication Critical patent/FI94314B/en
Application granted granted Critical
Publication of FI94314C publication Critical patent/FI94314C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)

Abstract

An agent containing salicylic acid for treating lepidosis in human and veterinary medicine contains 4 to 10 wt. % of salicylic acid, 1 to 7 wt. % of an aliphatic 1,2-diol, and 83 to 95 wt. % of a fatty oil, where the total weight of the agent = 100.
FI891357A 1987-07-25 1989-03-22 The method prepares a salicylic acid-containing substance against scaly skin diseases FI94314C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3724691 1987-07-25
DE3724691A DE3724691C2 (en) 1987-07-25 1987-07-25 Pharmaceutical agent for the local therapy of flaking skin diseases
PCT/EP1988/000649 WO1989000853A1 (en) 1987-07-25 1988-07-19 Agent containing salicylic acid for treating lepidosis
EP8800649 1988-07-19

Publications (4)

Publication Number Publication Date
FI891357A0 FI891357A0 (en) 1989-03-22
FI891357A true FI891357A (en) 1989-03-22
FI94314B FI94314B (en) 1995-05-15
FI94314C FI94314C (en) 1995-08-25

Family

ID=6332361

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891357A FI94314C (en) 1987-07-25 1989-03-22 The method prepares a salicylic acid-containing substance against scaly skin diseases

Country Status (9)

Country Link
EP (1) EP0325628B1 (en)
JP (1) JPH02500106A (en)
AT (1) ATE69550T1 (en)
AU (1) AU2072088A (en)
DE (2) DE3724691C2 (en)
DK (1) DK173547B1 (en)
FI (1) FI94314C (en)
NO (1) NO175885C (en)
WO (1) WO1989000853A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001303B (en) * 1989-01-23 1993-07-30 Wolff Chem Pharm Gmbh Method for preparation of a means that contains salicyloxyd against scaling sick
ATE91079T1 (en) * 1989-01-25 1993-07-15 Wolff Chem Pharm Gmbh SALICYLIC ACID AGENT AGAINST SCALPING SKIN DISEASES.
GB9223034D0 (en) * 1992-11-03 1992-12-16 Surtech Int Ltd Method and composition for prevention and/or treatment of dandruff and seborrhoeic dermatitis
SE9403541L (en) * 1994-10-14 1996-04-15 Sven Moberg Antimicrobial composition
US5736580A (en) * 1994-11-14 1998-04-07 Alza Croporation Composition, device, and method for electrotransport agent delivery
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US6623724B2 (en) 1996-09-18 2003-09-23 Applied Genetics Incorporated Dermatics Dermatological compositions and methods
AU740783B2 (en) * 1996-09-18 2001-11-15 Applied Genetics Incorporated Dermatics Pharmaceutical compositions and methods
DE10205193A1 (en) * 2002-02-08 2003-08-21 Beiersdorf Ag Cleaning preparations containing diol
DE10341179A1 (en) † 2003-09-06 2005-03-31 Beiersdorf Ag Cosmetic or dermatological preparations containing synergistic combination of alpha- or beta-hydroxyacid and alkanediol, useful for combating acne and/or Propionibacterium acnes infection
CN104105472A (en) 2011-12-20 2014-10-15 维奥姆生物科学有限公司 Topical oil composition for the treatment of fungal infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE762726C (en) * 1942-05-02 1952-09-15 Hydrierwerke A G Deutsche Solvent or solubilizer for salicylic acid
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
FR2585575B1 (en) * 1985-08-01 1989-03-03 Pf Medicament PHARMACEUTICAL COMPOSITIONS WITH KERATOLYTIC ACTIVITY IN GEL FORM COMPRISING HYDROALCOHOLIC SALICYLIC ACID

Also Published As

Publication number Publication date
DK173547B1 (en) 2001-02-19
DK137589D0 (en) 1989-03-21
DE3724691C2 (en) 1999-03-18
NO891220L (en) 1989-03-20
JPH02500106A (en) 1990-01-18
AU2072088A (en) 1989-03-01
EP0325628A1 (en) 1989-08-02
NO891220D0 (en) 1989-03-20
ATE69550T1 (en) 1991-12-15
DE3724691A1 (en) 1989-02-02
NO175885B (en) 1994-09-19
FI891357A0 (en) 1989-03-22
NO175885C (en) 1994-12-28
DE3866344D1 (en) 1992-01-02
FI94314B (en) 1995-05-15
DK137589A (en) 1989-05-19
WO1989000853A1 (en) 1989-02-09
FI94314C (en) 1995-08-25
EP0325628B1 (en) 1991-11-21

Similar Documents

Publication Publication Date Title
SE9401406L (en) Pharmaceutical products for the cure of tumor diseases as well as a method for the preparation thereof
ATE75397T1 (en) USE OF VITAMIN E IN THE MANUFACTURE OF PHARMACEUTICALS FOR THE NORMALIZATION OF BLOOD COAGLING IN THERAPY WITH OMEGA-3 TYPE HIGH UNSATURATED FATTY ACIDS.
DE3382641D1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF ALOPEZIA.
DE3582439D1 (en) MEDICINE FOR TREATING HEART DISEASES.
FI891357A (en) Process for Preparation of Salicylic Acid Derivative against Dandruff Skin Diseases
ATE120954T1 (en) USE OF ESSENTIAL FATTY ACIDS TO PRODUCE A MEDICINAL PRODUCT FOR THE TREATMENT OF AIDS.
ES8102141A1 (en) 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds
DE68926115T2 (en) METHOD FOR TREATING ACNE
IT8721115A0 (en) PHYTO-PREPARATION FOR THE TREATMENT OF SKIN DISEASES.
ES8205190A1 (en) 3,7,11,15-Tetramethyl- 2,4,6,10,14-hexadecapentaenoic Acid
DE3784628D1 (en) DERMAL TREATMENT OF CAT WORM DISEASES WITH PRAZIQUANTEL.
DE3268159D1 (en) Medicaments based on algae, and formulations thereof
ES2006121A6 (en) Method for treating skin diseases
ES8201955A1 (en) 2-Hydroxyoxanilic acid derivatives and salts, their preparation and pharmaceutical compositions containing them.
DE3373978D1 (en) Composition for the care or treatment of the human skin
GR3001793T3 (en) Polyprenyl alcohol-containing injections and use thereof
DE3578374D1 (en) USE OF CHINOLONES FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HEART DISEASES.
DE58904851D1 (en) SALICYL ACID CONTAINER AGAINST Dandruff Skin Diseases.
FR2619716B1 (en) DRUG AND VETERINARY PRODUCT FOR THE TREATMENT OF STERILITY
SE8800101L (en) APPLICATION OF ESSENTIAL FAT ACIDS FOR THE PREPARATION OF A PREPARATION FOR THE TREATMENT OF ECSMA
FR2627487B1 (en) NEW DERIVATIVE OF VALPROIC ACID, PROCESS FOR THE PREPARATION OF THIS COMPOUND AND THE ANTIPLEPTIC MEDICINE CONTAINING THE SAME
GR890100035A (en) Method for preparation of a means that contains salicyloxyd against scaling sick
SU1744810A1 (en) Vasoactive agent "dimephosphone" normalizing vegetative nervous system functions

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: MINNINGER, KONRAD

MA Patent expired